MEDICINOVA, INC. Repayments of Other Debt
MEDICINOVA, INC. (MNOV) reported Repayments of Other Debt of $17.61 million for the 156-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherDebt · last filed 2013-11-07
- MEDICINOVA, INC. repayments of other debt for the quarter ending 2013-09-30 was $0.00.
| Period end | Repayments of Other Debt 3 month | Repayments of Other Debt 153 month | Repayments of Other Debt 156 month |
|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 156 month − 10-Q 153 month · filed 2013-11-07 | $17.61M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $17.61M 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |